Eli Lilly and Company (LLY.DE) Stock Price

€610.1 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    7

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Eli Lilly and Company, AI stock picks, stock alerts and much more.

Sign up

LLY.DE AI Stock Analysis

AI stock analysis for LLY.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Eli Lilly and Company (LLY.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Eli Lilly and Company (LLY.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eli Lilly and Company (LLY.DE), currently trading at €610.1, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About LLY.DE

LSE

  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.

  • Symbol

    LLY.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - General

  • Market Cap

    577.4B

Similar Stocks

PFE.F Pfizer Inc.
PFE.F		 €21.97
1%
5
AMG.DE Amgen Inc.
AMG.DE		 €251.6
2.3%
6
ZEG.DE AstraZeneca PLC
ZEG.DE		 €138.4
0.7%
7
PFE.DE Pfizer Inc.
PFE.DE		 €22.11
0.7%
5
IDP.DE Biogen Inc.
IDP.DE		 €119.8
0.3%
7

News

Lilly Sues 4 Compounders Over Copies of Weight-Loss Drugs

Lilly Sues 4 Compounders Over Copies of Weight-Loss Drugs
April 24, 2025. Insurance Journal
SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago

SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago
April 24, 2025. GlobeNewswire
Trump changes tone over tariffs on China. And, new executive actions target education

Trump changes tone over tariffs on China. And, new executive actions target education
April 24, 2025. NPR
FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients

FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients
April 23, 2025. The-independent.com

LLY.DE Alternative Data

Web Traffic

Eli Lilly and Company receives an estimated 4.6M monthly visitors to lilly.com.

  • Web Traffic

    4613034

  • Change from Previous Month

    0.3%

  • 3 Month Change

    5%

  • YoY Change

    5%

Twitter Followers

Eli Lilly and Company has 143,316 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.

  • Twitter Followers

    143316

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

Facebook Engagement

Eli Lilly and Company has engaged 7,653 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    7653

  • Daily Change

    7%

  • 1 Month Change

    3%

  • 3 Month Change

    29.6%

  • YoY Change

    29.6%

Youtube Subscribers

Eli Lilly and Company has 23,900 subscribers on its main Youtube channel, up by 0.4% over the last month.

  • Youtube Subscribers

    23900

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    2.6%

  • YoY Change

    2.6%

Job Postings

Eli Lilly and Company has an estimated 969 open job postings, which is down -3.1% over the last month.

  • Job Postings

    969

  • Daily Change

    0.9%

  • 1 Month Change

    3.1%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Reddit Mentions

Eli Lilly and Company has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Instagram Followers

Eli Lilly and Company has 49,472 Instagram Followers on its main Instagram account, up by 2.4% over the last month.

  • Instagram Followers

    49472

  • Daily Change

    0.1%

  • 1 Month Change

    2.4%

  • 3 Month Change

    11.2%

  • YoY Change

    11.2%

App Downloads

  • App Downloads

    16000

LinkedIn Followers

2,218,962 are following Eli Lilly and Company on LinkedIn, up by 3.1% over the last month.

  • LinkedIn Followers

    2218962

  • Daily Change

    3.1%

  • 1 Month Change

    3.1%

  • 3 Month Change

    6.8%

  • YoY Change

    6.8%

LinkedIn Employees

According to LinkedIn, Eli Lilly and Company has 51,576 employees, up by 1.1% over the last month.

  • LinkedIn Employees

    51576

  • Daily Change

    1.1%

  • 1 Month Change

    1.1%

  • 3 Month Change

    4%

  • YoY Change

    4%

Business Outlook

According to employee reviews, the business outlook among employees at Eli Lilly and Company is 85 out of 100 (very bullish).

  • Business Outlook

    85

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Eli Lilly and Company was mentioned 13 times in the news yesterday.

  • News Mentions

    13

  • Daily Change

    35%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LLY.DE Financials

LLY.DE Key Metrics

  • Total Revenue

    $12.7B

  • Net Income

    $2.8B

  • Earnings per Share

    $3.07

  • Free cash flow

    -$1.6B

  • EBITDA

    $4.2B

  • EBITDA Ratio

    0.32703

  • Total Assets

    $89.4B

LLY.DE 2-year Revenue & Income
LLY.DE 2-year Free Cash Flow

LLY.DE Technicals

LLY.DE SMA
LLY.DE RSI

FAQ

What's the current price of Eli Lilly and Company (LLY.DE) Stock?
The price of an Eli Lilly and Company (LLY.DE) share is €610.1.

What's the market cap of Eli Lilly and Company?
The current market cap of Eli Lilly and Company is 577.4B.

Should I buy or sell LLY.DE?
Multiple alternative data signals suggest that Eli Lilly and Company stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Eli Lilly and Company a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Eli Lilly and Company stock. The bullish indicators suggest that Eli Lilly and Company's growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Eli Lilly and Company (LLY.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Eli Lilly and Company stock, given the bullish outlook.

What are some stocks similar to Eli Lilly and Company (LLY.DE) that investors often compare it to?
Eli Lilly and Company (LLY.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., AstraZeneca PLC, Pfizer Inc. and Biogen Inc..

What is the forecast for Eli Lilly and Company's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Eli Lilly and Company's stock price to be around €653.4 in 2026. Starting from the current price of €610.1, this represents a 7.1% change in price, indicating a bullish outlook for the stock.

How to buy Eli Lilly and Company (LLY.DE) Stock?
Eli Lilly and Company stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Eli Lilly and Company shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.